In Vitro Diagnostic (IVD) Reagent Market To Witness Proliferating Demand for Chemical Reagents

Dublin, Ireland, 2022-Aug-30 — /EPR Network/ —

The rapid expansion of the IVD Reagent market is due to an increase in healthcare spending and demand for genomic and proteomic services. Furthermore, in most countries, obtaining approval from regulatory bodies to perform diagnostic tests has become a must for all clinical laboratories, which contributes to the growth of the IVD reagents market. Countries such as Ireland, France, and Belgium, for example, have made certification for a variety of laboratory tests mandatory.

In addition, the market is expected to grow due to technological advancements in in vitro diagnostic products, technologies, software, and services.

Chemical, biochemical, and immune-chemical reagents are the three categories of in-vitro diagnostic reagents employed. Chemical reagents, which include dyes, surfactants, buffers, and basic compounds, are the most common IVD reagents. Biochemical and immunochemical reagents, for example, are more complicated, with multiple processes and working components. Hence, chemical reagents market is expected to witness positive growth in the coming years

For Critical Insights On This Market, Request For More Info –

The COVID-19 epidemic prompted international lockdowns in order to monitor social distance. These lockdowns had a significant influence on every industry and business. Similarly, the COVID-19 outbreak had an impact on the in vitro diagnostics sector. Multiple diagnostic test manufacturers have developed and began offering various tests and kits prepared utilizing IVD reagents in response to the COVID-19 epidemic and shortages of laboratory-based molecular testing capacity and reagents. These easy test kits are based on the detection of COVID-19 viral proteins in respiratory samples or the identification of human antibodies developed in response to infection in blood or serum. As a result of the pandemic, the use of IVD reagents for kits and assay preparation using immunoassay and molecular diagnostics technology has increased.

According to the report, North America has emerged as the most prominent region due to improved technology, laboratory automation, a surge in the use of molecular diagnostics for cancer screening and genetic disorders, and the presence of top manufacturers in the region

Key Takeaways from In Vitro Diagnostic (IVD) Reagent Market Survey

  • North America leads the in vitro diagnostic reagent market owing to technological advancements.
  • South Asia region is expected to be the fastest-growing region in the market owing to development of healthcare infrastructure and increase healthcare spending.
  • Application of IVD reagents in clinical chemistry and special chemistry testing laboratories to witness positive growth.

Key Drivers

  • Rising incidences of acute and chronic infectious diseases coupled with growing geriatric population to drive the in vitro diagnostic reagent market.
  • Usage of flow cytometry techniques in research and academia and rising proteomics and genomics research studies to propel the demand of in vitro diagnostic reagents.

Key Restraints

  • In most countries, the reimbursement situation for IVD tests is complex, stifling the growth of the IVD Reagent market.

Ask Your In Vitro Diagnostic (IVD) Reagent Market Related Questions & Get Customized Report

Competitive Landscape

Some of the prominent players operating in the in vitro diagnostic (IVD) reagent market profiled by Fact.MR are:

  • Biokit
  • EKF Diagnostic Holdings
  • Meridian Life Science
  • Polymed Therapeutics

More Insights on the In Vitro Diagnostic (IVD) Reagent Sales Outlook

Fact.MR provides an unbiased analysis of in vitro diagnostic (IVD) reagent market, presenting forecast statistics for the period from 2019-2029. The study divulges compelling insights on the global demand for in vitro diagnostic reagents with a detailed segmentation on the basis of:


  • Chemical
  • Bio-chemical
  • Immunochemical


  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others


  • Healthcare Institutes
  • Independent Laboratories
  • Research Institutes


  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa (MEA)

Key Questions Covered in the In Vitro Diagnostic (IVD) Reagent Market Outlook Report

  • The report offers insight into in vitro diagnostic reagents demand outlook for 2019-2029
  • The market study also highlights projected sales growth for in-vitro diagnostic reagents market between 2019 and 2029
  • In vitro diagnostic reagents market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • In vitro diagnostic reagents market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Explore Fact.MR’s Coverage on the Healthcare Domain –

PCR and Real-time PCR Molecular Diagnostics Market – The COVID-19 pandemic has boosted prospects for the growth of the PCR and real-time PCR molecular diagnostics market. Real-time (qPCR) and digital (dPCR) PCR tests have been used in a variety of healthcare settings to detect and diagnose potential cases.

In Vitro Diagnostics Test Kit Market– The expanding geriatric population in both developed and developing countries would benefit the IVD market. As the world’s old population grows fast, the prevalence of age-related illnesses is expected to climb considerably.

Rapid Medical Diagnostic Kits Market– Infectious disease incidence has been steadily increasing over the last few decades, driving up demand for rapid medical diagnostic kits around the world. The need to detect novel pathogens that cause diseases is propelling the market forward.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Matched content

Editor’s pick

Express Press Release Distribution